Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - comparison of pharmacology and clinical efficacy
<p>Abstract</p> <p>The incidence of nosocomial pneumonia involving methicillin-resistant <it>Staphylococcus aureus </it>strains (MRSA) is on the rise worldwide. For years, vancomycin has been used as the drug of choice in the treatment of MRSA infections and was recomme...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-11-01
|
| Series: | European Journal of Medical Research |
| Online Access: | http://www.eurjmedres.com/content/15/12/507 |